The investigation concluded that a lower than expected vitros myoglobin (myog) quality control (qc) result was obtained using a non-vitros (biorad) qc fluid in combination with a vitros 5600 integrated system.A definitive assignable cause of the event could not be determined.Historical qc results for vitros myog lot 1321 were reviewed and were acceptable with respect to accuracy and precision.However, ortho has become aware of a calibrator stability issue post reconstitution and this issue is being investigated.There was also no indication of an instrument malfunction and unexpected instrument performance is not a likely contributor to the event.However, the customer did not perform a within run precision test when requested at the time of the event to definitively rule out an instrument issue.A definitive assignable cause of the event could not be determined.
|
The actual product impacted by this event is the vitros immunodiagnostics products myoglobin calibrators, not the vitros immunodiagnostic products myoglobin reagent pack.Therefore, the brand name, common device name, catalogue # and unique device identifier have been corrected.Investigation into the root cause is still in progress, but the issue is linked to the stability of the vitros myoglobin calibrators post reconstitution by the user.Ortho has issued field action with the following instructions to the end user.1.Reconstitute the calibrators using 1.0 ml distilled water, as per current instructions.2.Allow reconstituted calibrator vials to stand at room temperature for 2 hours and then proceed with calibration within 2 hours (4 hours total).3, discard reconstituted calibrators after 4 hours.Ortho notified the fda¿s new york district office of this field action on 30 november 2018.
|